The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.
Anti-TNF-α therapies: the next generation
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An endotoxin-induced serum factor that causes necrosis of tumors
Carswell, E. A., Old, L. J., Kassel, R. L., Green, S., Fiore, N., & Williamson, B. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.9.3666 · Cited by 4,532
Tracey, K. J. (2002) · Nature · doi:10.1038/nature01321 · Cited by 3,728
Multiple nuclear factors interact with the immunoglobulin enhancer sequences
Sen, R., & Baltimore, D. (1986) · Cell · doi:10.1016/0092-8674(86)90346-6 · Cited by 2,752
Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin
Pennica, D., Nedwin, G. E., Hayflick, J. S., Seeburg, P. H., Derynck, R., Palladino, M. A., Kohr, W. J., Aggarwal, B. B., & Goeddel, D. V. (1984) · Nature · doi:10.1038/312724a0 · Cited by 1,736
Self-citationAn Essential Role for Ectodomain Shedding in Mammalian Development
Peschon, J. J., Slack, J. L., Reddy, P., Stocking, K. L., Sunnarborg, S. W., Lee, D. C., Russell, W. E., Castner, B. J., Johnson, R. S., Fitzner, J. N., et al. (1998) · Science · doi:10.1126/science.282.5392.1281 · Cited by 1,607
Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-α
Moss, M. L., Jin, S.-L. C., Milla, M. E., Burkhart, W., Carter, H. L., Chen, W.-J., Clay, W. C., Didsbury, J. R., Hassler, D., Hoffman, C. R., et al. (1997) · Nature · doi:10.1038/385733a0 · Cited by 1,378
Identity of tumour necrosis factor and the macrophage-secreted factor cachectin
Beutler, B., Greenwald, D., Hulmes, J. D., Chang, M., Pan, Y.-C. E., Mathison, J., Ulevitch, R., & Cerami, A. (1985) · Nature · doi:10.1038/316552a0 · Cited by 1,131
Induction of apoptosis in mature T cells by tumour necrosis factor
Zheng, L., Fisher, G., Miller, R. E., Peschon, J., Lynch, D. H., & Lenardo, M. J. (1995) · Nature · doi:10.1038/377348a0 · Cited by 1,116
Kriegler, M., Perez, C., DeFay, K., Albert, I., & Lu, S. D. (1988) · Cell · doi:10.1016/0092-8674(88)90486-2 · Cited by 1,102
Proteolytic Inactivation of MAP-Kinase-Kinase by Anthrax Lethal Factor
Duesbery, N. S., Webb, C. P., Leppla, S. H., Gordon, V. M., Klimpel, K. R., Copeland, T. D., Ahn, N. G., Oskarsson, M. K., Fukasawa, K., Paull, K. D., et al. (1998) · Science · doi:10.1126/science.280.5364.734 · Cited by 1,008
Leppla, S. H. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.10.3162 · Cited by 935
Mock, M., & Fouet, A. (2001) · Annual Review of Microbiology · doi:10.1146/annurev.micro.55.1.647 · Cited by 894
Dixon, T. C., Meselson, M., Guillemin, J., & Hanna, P. C. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909093411107 · Cited by 874
Van Zee, K. J., Kohno, T., Fischer, E., Rock, C. S., Moldawer, L. L., & Lowry, S. F. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.11.4845 · Cited by 845
Self-citationIdentification of the cellular receptor for anthrax toxin
Bradley, K. A., Mogridge, J., Mourez, M., Collier, R. J., & Young, J. A. T. (2001) · Nature · doi:10.1038/n35101999 · Cited by 843
Beutler, B., Mahoney, J., Le Trang, N., Pekala, P., & Cerami, A. (1985) · The Journal of experimental medicine · doi:10.1084/jem.161.5.984 · Cited by 821
Crystal structure of the anthrax toxin protective antigen
Petosa, C., Collier, R. J., Klimpel, K. R., Leppla, S. H., & Liddington, R. C. (1997) · Nature · doi:10.1038/385833a0 · Cited by 755
Macrophages are sensitive to anthrax lethal toxin through an acid-dependent process.
Friedlander, A. M. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38364-3 · Cited by 612
Saxne, T., Palladino, M. A., Heinegãrd, D., Talal, N., & Wollheim, F. A. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310816 · Cited by 566
Self-citationTartaglia, L. A., Pennica, D., & Goeddel, D. V. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)46661-0 · Cited by 562
Burke, J. R., Pattoli, M. A., Gregor, K. R., Brassil, P. J., MacMaster, J. F., McIntyre, K. W., Yang, X., Iotzova, V. S., Clarke, W., Strnad, J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209677200 · Cited by 550
Kwok, B. H. B., Koh, B., Ndubuisi, M. I., Elofsson, M., & Crews, C. M. (2001) · Chemistry & Biology · doi:10.1016/s1074-5521(01)00049-7 · Cited by 515
Han, J., Thompson, P., & Beutler, B. (1990) · The Journal of experimental medicine · doi:10.1084/jem.172.1.391 · Cited by 508
Macrophage Apoptosis by Anthrax Lethal Factor Through p38 MAP Kinase Inhibition
Park, J. M., Greten, F. R., Li, Z.-W., & Karin, M. (2002) · Science · doi:10.1126/science.1073163 · Cited by 500
The type 1 receptor (CD120a) is the high-affinity receptor for soluble tumor necrosis factor
Grell, M., Wajant, H., Zimmermann, G., & Scheurich, P. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.2.570 · Cited by 478
Coley's toxins, tumor necrosis factor and cancer research: A historical perspective
Wiemann, B., & Starnes, C. O. (1994) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(94)90023-x · Cited by 467
Joosten, L. A. B., Helsen, M. M., Saxne, T., van de Loo, F. A. J., Heinegård, D. K., & van den Berg, W. B. (1999) · PubMed · Cited by 441
Engelmann, H., Aderka, D., Rubinstein, M., Rotman, D., & Wallach, D. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)80162-4 · Cited by 440
Rasmussen, H. S., & McCann, P. P. (1997) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(97)00023-5 · Cited by 413
Joosten, L. A. B., Helsen, M. M. A., Saxne, T., van de Loo, F. A. J., Heinegård, D., & van den Berg, W. B. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.9.5049 · Cited by 405
Baecklund, E., Ekbom, A., Sparén, P., Feltelius, N., & Klareskog, L. (1998) · BMJ · doi:10.1136/bmj.317.7152.180 · Cited by 394
Cloning and expression in Escherichia coli of the cDNA for murine tumor necrosis factor.
Pennica, D., Hayflick, J. S., Bringman, T. S., Palladino, M. A., & Goeddel, D. V. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.18.6060 · Cited by 390
Self-citationVitale, G., Bernardi, L., Napolitani, G., Mock, M., & Montecucco, C. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3520739 · Cited by 355
Hehner, S. P., Heinrich, M., Bork, P. M., Vogt, M., Ratter, F., Lehmann, V., Schulze-Osthoff, K., Dröge, W., & Schmitz, M. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.3.1288 · Cited by 338
Buchan, G. S., Barrett, K., Turner, M., Chantry, D., Maini, R. N., & Feldmann, M. (1988) · PubMed Central · Cited by 332
Studies of endotoxin-induced decrease in lipoprotein lipase activity.
Kawakami, M., & Cerami, A. (1981) · The Journal of experimental medicine · doi:10.1084/jem.154.3.631 · Cited by 327
On the role of macrophages in anthrax.
Hanna, P. C., Acosta, D., & Collier, R. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.21.10198 · Cited by 301
Signaling Molecules of the NF-κB Pathway Shuttle Constitutively between Cytoplasm and Nucleus
Birbach, A., Gold, P., Binder, B. R., Hofer, E., de Martin, R., & Schmid, J. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112475200 · Cited by 299
Dredge, K., Marriott, J. B., Macdonald, C. D., Man, H.-W., Chen, R., Muller, G. W., Stirling, D., & Dalgleish, A. G. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600607 · Cited by 296
Endotoxin induces rapid protein tyrosine phosphorylation in 70Z/3 cells expressing CD14.
Han, J., Lee, J. D., Tobias, P. S., & Ulevitch, R. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74564-5 · Cited by 292
Differences in susceptibility of inbred mice to Bacillus anthracis
Welkos, S. L., Keener, T. J., & Gibbs, P. H. (1986) · Infection and Immunity · doi:10.1128/iai.51.3.795-800.1986 · Cited by 279
Ekström, K., Hjalgrim, H., Brandt, L., Baecklund, E., Klareskog, L., Ekbom, A., & Askling, J. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10939 · Cited by 267
A human inhibitor of tumor necrosis factor alpha.
Seckinger, P., Isaaz, S., & Dayer, J. M. (1988) · The Journal of experimental medicine · doi:10.1084/jem.167.4.1511 · Cited by 255
Isolation and characterization of a tumor necrosis factor binding protein from urine
Olsson, I., Lantz, M., Nilsson, E., Peetre, C., Thysell, H., Grubb, A., & Adolf, G. (1989) · European Journal of Haematology · doi:10.1111/j.1600-0609.1989.tb00111.x · Cited by 245
Role of I Bα Ubiquitination in Signal-induced Activation of NF- B in Vivo
Roff, M., Thompson, J., Rodriguez, M. S., Jacque, J.-M., Baleux, F., Arenzana-Seisdedos, F., & Hay, R. T. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.13.7844 · Cited by 214
Species differences in pharmacokinetics and drug teratogenesis.
Nau, H. (1986) · Environmental Health Perspectives · doi:10.1289/ehp.8670113 · Cited by 199
喬, 嶋. (1992) · doi:10.11381/jjcdp1974.26.198 · Cited by 187
Role of IKK1 and IKK2 in Lipopolysaccharide Signaling in Human Monocytic Cells
O'Connell, M. A., Bennett, B. L., Mercurio, F., Manning, A. M., & Mackman, N. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.46.30410 · Cited by 184
Thalidomide in the Treatment of Relapsed Multiple Myeloma
Rajkumar, S. V., Fonseca, R., Dispenzieri, A., Lacy, M. Q., Lust, J. A., Witzig, T. E., Kyle, R. A., Gertz, M. A., & Greipp, P. R. (2000) · Mayo Clinic Proceedings · doi:10.4065/75.9.897 · Cited by 183
Baecklund, E., Sundström, C., Ekbom, A., Catrina, A. I., Biberfeld, P., Feltelius, N., & Klareskog, L. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11144 · Cited by 180
Küsters, S., Tiegs, G., Alexopoulou, L., Pasparakis, M., Douni, E., Künstle, G., Bluethmann, H., Wendel, A., Pfizenmaier, K., Kollias, G., et al. (1997) · European Journal of Immunology · doi:10.1002/eji.1830271119 · Cited by 176
Evans, T. J., Moyes, D., Carpenter, A., Martin, R., Loetscher, H., Lesslauer, W., & Cohen, J. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.6.2173 · Cited by 174
Thalidomide for previously untreated indolent or smoldering multiple myeloma
Rajkumar, S., Dispenzieri, A., Fonseca, R., Lacy, M., Geyer, S., Lust, J., Kyle, R., Greipp, P., Gertz, M., & Witzig, T. (2001) · Leukemia · doi:10.1038/sj.leu.2402183 · Cited by 164
The alveolar macrophage: the Trojan horse of Bacillus anthracis
Guidi-Rontani, C. (2002) · Trends in Microbiology · doi:10.1016/s0966-842x(02)02422-8 · Cited by 164
Dredge, K., Marriott, J. B., Todryk, S. M., Muller, G. W., Chen, R., Stirling, D. I., & Dalgleish, A. G. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.10.4914 · Cited by 162
Probert, L., Plows, D., Kontogeorgos, G., et al. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250647 · Cited by 157
Singh, S., Natarajan, K., & Aggarwal, B. B. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.10.4412 · Cited by 150
Grell, M., Becke, F. M., Wajant, H., Männel, D. N., & Scheurich, P. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199801)28:01<257::aid-immu257>3.0.co;2-g · Cited by 150
Butler, D., Malfait, A., Mason, L. J., Warden, P., Kollias, G. A., Maini, R. N., Feldmann, M., & Brennan, F. M. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.6.2867 · Cited by 149
Alexopoulou, L., Pasparakis, M., & Kollias, G. A. (1997) · European Journal of Immunology · doi:10.1002/eji.1830271018 · Cited by 141
Simeonova, P. P., & Luster, M. I. (1995) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.12.6.7539275 · Cited by 137
Lee, J.-H., Koo, T. H., Hwang, B. Y., & Lee, J. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201368200 · Cited by 135
Douni, E. K., & Kollias, G. A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.7.1343 · Cited by 125
Recent Advances in PDE4 Inhibitors as Immunoregulators and Anti- Inflammatory Drugs
Burnouf, C., & Pruniaux, M. (2002) · Current Pharmaceutical Design · doi:10.2174/1381612023394665 · Cited by 124
A review of angiogenesis and antiangiogenic therapy with thalidomide in multiple myeloma
Rajkumar, S. V., & Witzig, T. E. (2000) · Cancer Treatment Reviews · doi:10.1053/ctrv.2000.0188 · Cited by 123
Welkos, S. L., & Friedlander, A. M. (1988) · Microbial Pathogenesis · doi:10.1016/0882-4010(88)90015-0 · Cited by 118
Proteasome Activity Is Required for Anthrax Lethal Toxin To Kill Macrophages
Tang, G., & Leppla, S. H. (1999) · Infection and Immunity · doi:10.1128/iai.67.6.3055-3060.1999 · Cited by 118
Sheehan, M., Wong, H. R., Hake, P. W., Malhotra, V., O’Connor, M., & Zingarelli, B. (2002) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12190-6 · Cited by 112
Josephs, M. D., Bahjat, F. R., Fukuzuka, K., Ksontini, R., Solórzano, C. C., Edwards, C. K., Tannahill, C. L., MacKay, S. L. D., Copeland, E. M., & Moldawer, L. L. (2000) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2000.278.5.r1196 · Cited by 111
Self-citationUncoupling of inflammatory and destructive mechanisms in arthritis
van den Berg, W. B. (2001) · Seminars in Arthritis and Rheumatism · doi:10.1053/sarh.2001.23704 · Cited by 109
Transgenic and knockout analyses of the role of TNF in immune regulation and disease pathogenesis.
Douni, E. K., Akassoglou, K., Alexopoulou, L., Georgopoulos, S., Haralambous, S., Hill, S., Kassiotis, G., Kontoyiannis, D. L., Pasparakis, M., Plows, D., et al. (1995) · PubMed · Cited by 104
Phosphodiesterase 4 (PDE4) inhibitors in asthma and chronic obstructive pulmonary disease (COPD)
Barnette, M. S. (1999) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8735-9_5 · Cited by 98
Kif1C, a kinesin-like motor protein, mediates mouse macrophage resistance to anthrax lethal factor
Watters, J., Dewar, K., Lehoczky, J. A., et al. (2001) · Current Biology · doi:10.1016/s0960-9822(01)00476-6 · Cited by 91
Alexander‐Miller, M. A., Derby, M. A., Sarin, A., Henkart, P. A., & Berzofsky, J. A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.8.1391 · Cited by 90
Cytokine production in synovial tissue of mice with collagen-induced arthritis (CIA)
MÜSSENER, Å., Litton, M. J., Lindroos, E., & Klareskog, L. (1997) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1997.3181214.x · Cited by 85
Anti-TNF.ALPHA. Therapy for Rheumatoid Arthritis: An Update.
Taylor, P. C. (2003) · Internal Medicine · doi:10.2169/internalmedicine.42.15 · Cited by 81
Kim, S. O., Jing, Q., Hoebe, K. H. N., Beutler, B., Duesbery, N. S., & Han, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209279200 · Cited by 78
VX-745. Vertex Pharmaceuticals.
Haddad, J. J. (2001) · PubMed · Cited by 77
Neubert, R. T., Hinz, N., Thiel, R., & Neubert, D. (1995) · Life Sciences · doi:10.1016/0024-3205(95)02290-2 · Cited by 76
Development status of second generation PDE4 inhibitors for asthma and COPD: the story so far.
Giembycz, M. A. (2002) · PubMed · Cited by 74
Kim, E. J., Jin, H. K., Kim, Y. K., et al. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00538-x · Cited by 52
Immunological Effects of Thalidomide and Its Chemical and Functional Analogs
Dredge, K. S., Marriott, J. B., & Dalgleish, A. G. (2002) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v22.i5-6.40 · Cited by 51
Lin, H., Chen, C., & Chen, B. D. ‐. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3530299 · Cited by 51
Marriott, J. B., Clarke, I., Czajka, A., Dredge, K. S., Childs, K., Man, H., Schafer, P. H., Govinda, S., Muller, G. W., Stirling, D., et al. (2003) · PubMed · Cited by 50
Klug, S., Felies, A., Stürje, H., Nogueira, A. C. D. A., Neubert, R. T., & FRANKUS, E. (1994) · Archives of Toxicology · doi:10.1007/s002040050055 · Cited by 44
Thalidomide analogs as emerging anti-cancer drugs
Dredge, K. S., Dalgleish, A. G., & Marriott, J. B. (2003) · Anti-Cancer Drugs · doi:10.1097/00001813-200306000-00001 · Cited by 42
Embryotoxic effects of thalidomide derivatives in the non-human primate Callithrix jacchus
Neubert, D., Heger, W., Merker, H., Sames, K., & Meister, R. (1988) · Archives of Toxicology · doi:10.1007/bf00316632 · Cited by 39
Lange, R. W., Hayden, P. J., Chignell, C. F., & Luster, M. I. (1998) · Inflammation Research · doi:10.1007/s000110050313 · Cited by 35
Christen, U., Thuerkauf, R., Stevens, R. M., & Lesslauer, W. (1999) · Human Immunology · doi:10.1016/s0198-8859(99)00068-3 · Cited by 34
Tsuji, F., Oki, K., Okahara, A., Suhara, H., Yamanouchi, T., Sasano, M., Mita, S., & Horiuchi, M. (2002) · Cytokine · doi:10.1006/cyto.2002.1015 · Cited by 33
Thalidomide in multiple myeloma
Rajkumar, S. V. (2005) · Community Oncology · doi:10.1016/s1548-5315(11)70861-0 · Cited by 33
Current status of thalidomide in the treatment of cancer.
Rajkumar, S. V. (2001) · PubMed · Cited by 29
Manna, S. K., Bueso-Ramos, C., Alvarado, F., & Aggarwal, B. B. (2003) · Cancer Letters · doi:10.1016/s0304-3835(02)00618-3 · Cited by 15
Cited by
Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems
Takayanagi, H. (2007) · Nature Reviews Immunology · doi:10.1038/nri2062 · Cited by 1,878
Serbina, N. V., & Pamer, E. G. (2006) · Nature Immunology · doi:10.1038/ni1309 · Cited by 1,669
Glycans in cancer and inflammation — potential for therapeutics and diagnostics
Dube, D. H., & Bertozzi, C. R. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1751 · Cited by 1,598
Sato, K., Suematsu, A., Okamoto, K., Yamaguchi, A., Morishita, Y., Kadono, Y., Tanaka, S., Kodama, T., Akira, S., Iwakura, Y., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061775 · Cited by 1,554
Cytokines in clinical cancer immunotherapy
Berraondo, P., Sanmamed, M. F., Ochoa, M. C., Etxeberria, I., Aznar, M. A., Pérez-Gracia, J. L., Rodríguez-Ruiz, M. E., Ponz-Sarvise, M., Castañón, E., & Melero, I. (2019) · British Journal of Cancer · doi:10.1038/s41416-018-0328-y · Cited by 1,205
Metadata
- Authors
- Palladino, M. A., Bahjat, F. R., Theodorakis, E. A., & Moldawer, L. L.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2003-09
- Volume
- 2
- Issue
- 9
- Pages
- 736-746
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W1501675811
- Cited by
- 576
- References
- 93
- FWCI
- 3.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.